TrialDiabetes, obesity & metabolism2018

A first-in-human pharmacodynamic and pharmacokinetic study of a fully human anti-glucagon receptor monoclonal antibody in normal healthy volunteers.

Ana Kostic et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.